Idogen Overview
- Founded
- 2008
- Status
- Public
- Employees
- 9
- Stock Symbol
- IDOGEN
- Share Price
- $0.36
- (As of Tuesday Closing)
Idogen General Information
Description
Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Primary Office
- Medicon Village
- Scheelevagen 2
- 223 81 Lund
- Sweden
+46 046-275 00 00
Idogen Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.36 | $0.37 | $0.34 - $0.84 | $6.6M | 18.2M | 79.9K | -$0.36 |
Idogen Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 1,449 | 749 | 773 | 5,484 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (2,666) | (2,833) | (3,062) | (2,486) |
| Net Income | (2,865) | (3,457) | (3,176) | (2,495) |
| Total Assets | 3,665 | 3,336 | 7,974 | 5,397 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Idogen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Idogen‘s full profile, request access.
Request a free trialIdogen Executive Team (11)
Idogen Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000000 | Self | Co-Founder, Advisor & Board Member | 000 0000 |
| 000000 Ø000 | Ventac Partners | Board Member | 000 0000 |
Idogen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIdogen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Idogen‘s full profile, request access.
Request a free trial